Cognition, fatigue, depression and health-related quality of life in early multiple sclerosis: baseline data from CogniMS, a multinational longitudinal study

Trial Profile

Cognition, fatigue, depression and health-related quality of life in early multiple sclerosis: baseline data from CogniMS, a multinational longitudinal study

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2014

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms CogniMS
  • Sponsors Bayer HealthCare Pharmaceuticals
  • Most Recent Events

    • 02 Oct 2008 New trial record.
    • 18 Sep 2008 Results were presented at the World Congress on Treatment and Research in Multiple Sclerosis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top